69 related articles for article (PubMed ID: 25726051)
1. PET/MRI for evaluation of patients with pancreatic cancer.
Duncan ZN; Summerlin D; West JT; Packard AT; Morgan DE; Galgano SJ
Abdom Radiol (NY); 2023 Dec; 48(12):3601-3609. PubMed ID: 37191756
[TBL] [Abstract][Full Text] [Related]
2. Novel targets in pancreatic cancer research.
Kozak G; Blanco FF; Brody JR
Semin Oncol; 2015 Feb; 42(1):177-87. PubMed ID: 25726061
[TBL] [Abstract][Full Text] [Related]
3. Surgical management of pancreatic cancer--pancreaticoduodenectomy.
Donahue TR; Reber HA
Semin Oncol; 2015 Feb; 42(1):98-109. PubMed ID: 25726055
[TBL] [Abstract][Full Text] [Related]
4. PET/CT for Pancreatic Malignancy: Potential and Pitfalls.
Jha P; Bijan B
J Nucl Med Technol; 2015 Jun; 43(2):92-7. PubMed ID: 25857417
[TBL] [Abstract][Full Text] [Related]
5. New challenges in perioperative management of pancreatic cancer.
Puleo F; Maréchal R; Demetter P; Bali MA; Calomme A; Closset J; Bachet JB; Deviere J; Van Laethem JL
World J Gastroenterol; 2015 Feb; 21(8):2281-93. PubMed ID: 25741134
[TBL] [Abstract][Full Text] [Related]
6. The role of radiation therapy in pancreatic ductal adenocarcinoma in the neoadjuvant and adjuvant settings.
Franke AJ; Rosati LM; Pawlik TM; Kumar R; Herman JM
Semin Oncol; 2015 Feb; 42(1):144-62. PubMed ID: 25726059
[TBL] [Abstract][Full Text] [Related]
7. Surgical management of pancreatic cancer--distal pancreatectomy.
Parikh PY; Lillemoe KD
Semin Oncol; 2015 Feb; 42(1):110-22. PubMed ID: 25726056
[TBL] [Abstract][Full Text] [Related]
8. Premalignant cystic neoplasms of the pancreas.
Dudeja V; Allen PJ
Semin Oncol; 2015 Feb; 42(1):70-85. PubMed ID: 25726053
[TBL] [Abstract][Full Text] [Related]
9. "Infiltrative" Versus "Mass-Forming" Pancreatic Cancer: A New Radiological Classification System for Pancreatic Head Ductal Carcinoma and Its Pathological Correlation.
Darwish MB; Logarajah S; McLaren PJ; Benzie AL; Schmidt J; Saad AJ; Salicru M; Jackson T; Vedantam S; Carenza J; Sanders C; Nagatomo K; Cho E; Osman H; Jeyarajah DR
J Pancreat Cancer; 2022; 8(1):9-14. PubMed ID: 36583028
[TBL] [Abstract][Full Text] [Related]
10. PET imaging of Hsp90 expression in pancreatic cancer using a new
Wang X; Zhang J; Wu H; Li Y; Conti PS; Chen K
Amino Acids; 2018 Jul; 50(7):897-907. PubMed ID: 29691700
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of endoscopic ultrasound-guided fine needle aspiration for lymphadenopathy.
Tanisaka Y; Ryozawa S; Kobayashi M; Harada M; Kobatake T; Omiya K; Iwano H; Arai S; Nonaka K; Mashimo Y
Oncol Lett; 2018 Apr; 15(4):4759-4766. PubMed ID: 29552115
[TBL] [Abstract][Full Text] [Related]
12. Reply to the letter to the editor 'Borderline resectable pancreatic cancer: an evolving concept' by Petrucciani et al.
Gilbert JW; Wolpin B; Clancy T; Wang J; Mamon H; Shinagare AB; Jagannathan J; Rosenthal M
Ann Oncol; 2017 Sep; 28(9):2316. PubMed ID: 28541392
[No Abstract] [Full Text] [Related]
13. Borderline resectable pancreatic cancer: conceptual evolution and current approach to image-based classification.
Gilbert JW; Wolpin B; Clancy T; Wang J; Mamon H; Shinagare AB; Jagannathan J; Rosenthal M
Ann Oncol; 2017 Sep; 28(9):2067-2076. PubMed ID: 28407088
[TBL] [Abstract][Full Text] [Related]
14. Cross-sectional imaging and the role of positron emission tomography in pancreatic cancer evaluation.
Raman SP; Chen Y; Fishman EK
Semin Oncol; 2015 Feb; 42(1):40-58. PubMed ID: 25726051
[TBL] [Abstract][Full Text] [Related]
15. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
16. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in diagnosis and management of pancreatic cancer; comparison with multidetector row computed tomography, magnetic resonance imaging and endoscopic ultrasonography.
Ergul N; Gundogan C; Tozlu M; Toprak H; Kadıoglu H; Aydin M; Cermik TF
Rev Esp Med Nucl Imagen Mol; 2014; 33(3):159-64. PubMed ID: 24140024
[TBL] [Abstract][Full Text] [Related]
17. Impact of F18-fluorodeoxyglycose positron emission tomography/computed tomography on the management of resectable pancreatic tumours.
Yao J; Gan G; Farlow D; Laurence JM; Hollands M; Richardson A; Pleass HC; Lam VW
ANZ J Surg; 2012 Mar; 82(3):140-4. PubMed ID: 22510123
[TBL] [Abstract][Full Text] [Related]
18. Advances in imaging for pancreatic disease.
Del Frate C; Zanardi R; Mortele K; Ros PR
Curr Gastroenterol Rep; 2002 Apr; 4(2):140-8. PubMed ID: 11900679
[TBL] [Abstract][Full Text] [Related]
19. Multimodality imaging of pancreatic cancer-computed tomography, magnetic resonance imaging, and positron emission tomography.
Raman SP; Horton KM; Fishman EK
Cancer J; 2012; 18(6):511-22. PubMed ID: 23187837
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
